ITRM990309A0 - Composizione per il trattamento del prurito uremico e di forme di prurito non riconducibili a lesioni organiche. - Google Patents

Composizione per il trattamento del prurito uremico e di forme di prurito non riconducibili a lesioni organiche.

Info

Publication number
ITRM990309A0
ITRM990309A0 IT1999RM000309A ITRM990309A ITRM990309A0 IT RM990309 A0 ITRM990309 A0 IT RM990309A0 IT 1999RM000309 A IT1999RM000309 A IT 1999RM000309A IT RM990309 A ITRM990309 A IT RM990309A IT RM990309 A0 ITRM990309 A0 IT RM990309A0
Authority
IT
Italy
Prior art keywords
itching
attributable
treatment
composition
forms
Prior art date
Application number
IT1999RM000309A
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Publication of ITRM990309A0 publication Critical patent/ITRM990309A0/it
Priority to IT1999RM000309A priority Critical patent/IT1306141B1/it
Priority to CA002373296A priority patent/CA2373296C/en
Priority to EA200101205A priority patent/EA003792B1/ru
Priority to US10/009,225 priority patent/US7026319B1/en
Priority to DE60017251T priority patent/DE60017251T2/de
Priority to EP00935465A priority patent/EP1178801B1/en
Priority to AT00935465T priority patent/ATE286396T1/de
Priority to CNB008075948A priority patent/CN1159013C/zh
Priority to PCT/IT2000/000196 priority patent/WO2000069426A2/en
Priority to AU51003/00A priority patent/AU774343B2/en
Priority to ES00935465T priority patent/ES2233384T3/es
Priority to JP2000617885A priority patent/JP2002544225A/ja
Publication of ITRM990309A1 publication Critical patent/ITRM990309A1/it
Application granted granted Critical
Publication of IT1306141B1 publication Critical patent/IT1306141B1/it
Priority to US11/342,903 priority patent/US7291625B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT1999RM000309A 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche. IT1306141B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
AT00935465T ATE286396T1 (de) 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen
PCT/IT2000/000196 WO2000069426A2 (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
US10/009,225 US7026319B1 (en) 1999-05-17 2000-05-17 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation
DE60017251T DE60017251T2 (de) 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen
EP00935465A EP1178801B1 (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
CA002373296A CA2373296C (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
CNB008075948A CN1159013C (zh) 1999-05-17 2000-05-17 合并使用维生素用于治疗搔痒症和涉及搔痒和/或炎症的非感染性疾病
EA200101205A EA003792B1 (ru) 1999-05-17 2000-05-17 Применение комбинации витаминов для лечения зуда и неинфекционных заболеваний, приводящих к зуду и/или воспалению
AU51003/00A AU774343B2 (en) 1999-05-17 2000-05-17 Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation
ES00935465T ES2233384T3 (es) 1999-05-17 2000-05-17 Combinacion de acido nicotinico o nicotinamida con riboflavina para el tratamiento de trastornos que conllevan prurito, picor e inflamacion.
JP2000617885A JP2002544225A (ja) 1999-05-17 2000-05-17 そう痒症及びかゆみ及び／又は炎症を伴う非感染性疾病の治療のためのビタミンの組合せの使用
US11/342,903 US7291625B2 (en) 1999-05-17 2006-01-30 Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Publications (3)

Publication Number Publication Date
ITRM990309A0 true ITRM990309A0 (it) 1999-05-17
ITRM990309A1 ITRM990309A1 (it) 2000-11-17
IT1306141B1 IT1306141B1 (it) 2001-05-30

Family

ID=11406769

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Country Status (12)

Country Link
US (2) US7026319B1 (it)
EP (1) EP1178801B1 (it)
JP (1) JP2002544225A (it)
CN (1) CN1159013C (it)
AT (1) ATE286396T1 (it)
AU (1) AU774343B2 (it)
CA (1) CA2373296C (it)
DE (1) DE60017251T2 (it)
EA (1) EA003792B1 (it)
ES (1) ES2233384T3 (it)
IT (1) IT1306141B1 (it)
WO (1) WO2000069426A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
US6750234B2 (en) * 2001-03-08 2004-06-15 University Of Kentucky Research Foundation Methods for increasing leptin levels using nicotinic acid compounds
AR041089A1 (es) * 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents
EP2114154B1 (en) * 2007-02-08 2013-08-28 Merck Sharp & Dohme Corp. Method of treating atherosclerosis, dyslipidemias and related conditions
DK2271342T3 (da) * 2008-03-28 2012-10-29 Elanco Animal Health Ireland Anvendelse af nicotinamid til behandling af sommereksem hos heste
US8128949B2 (en) * 2008-04-14 2012-03-06 John Mosher Kit for insect bites
CN105142632B (zh) * 2012-06-27 2020-01-07 阿马曾提斯公司 通过投予尿石素或其前体增强自噬或增加寿命
KR20180021280A (ko) * 2016-08-18 2018-03-02 한양대학교 산학협력단 리보플라빈을 포함하는 가려움증 억제 또는 완화용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
US4265887A (en) * 1979-12-11 1981-05-05 Breskman Joseph S Composition and method for treatment of hemorrhoids
US4619829A (en) * 1982-11-16 1986-10-28 Georges Motschan Utilization of a single vitamin or a combination of various vitamins
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
JPS63188627A (ja) * 1987-01-31 1988-08-04 Rooto Seiyaku Kk 抗アレルギ−・抗炎症剤
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
CN1080855A (zh) * 1993-05-22 1994-01-19 黎均耀 维生素矿物质防癌复方
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
ATE201908T1 (de) * 1995-07-13 2001-06-15 Basf Ag Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase- aktivität
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
WO1999026636A1 (fr) * 1997-11-24 1999-06-03 Zhongming Zeng Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
WO1999047113A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance

Also Published As

Publication number Publication date
EP1178801A2 (en) 2002-02-13
DE60017251D1 (de) 2005-02-10
IT1306141B1 (it) 2001-05-30
CN1159013C (zh) 2004-07-28
US7026319B1 (en) 2006-04-11
JP2002544225A (ja) 2002-12-24
ES2233384T3 (es) 2005-06-16
ATE286396T1 (de) 2005-01-15
US20060178368A1 (en) 2006-08-10
US7291625B2 (en) 2007-11-06
EA003792B1 (ru) 2003-10-30
EP1178801B1 (en) 2005-01-05
EA200101205A1 (ru) 2002-04-25
AU5100300A (en) 2000-12-05
CN1350455A (zh) 2002-05-22
CA2373296A1 (en) 2000-11-23
CA2373296C (en) 2008-07-15
WO2000069426A2 (en) 2000-11-23
AU774343B2 (en) 2004-06-24
WO2000069426A3 (en) 2001-04-12
DE60017251T2 (de) 2005-12-15
ITRM990309A1 (it) 2000-11-17

Similar Documents

Publication Publication Date Title
BRPI0010891B8 (pt) geração de microespuma terapêutica.
IL183853A0 (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias
ATE259798T1 (de) Pharmazeutisch aktive verbindungen
ZA200104146B (en) Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males.
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
GB9918760D0 (en) Topical treatment
MXPA03002679A (es) Nuevo compuesto de oxabispidina util en el tratamiento de arritmias cardiacas.
HUP0400495A3 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
ZA200000578B (en) Process for the preparation of organic azides.
PT1192154E (pt) Compostos de bispidina uteis para o tratamento de arritmias cardiacas
IL146754A0 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
ZA200109858B (en) New bispidine compounds useful in the treatment of cardiac arrhythmias.
IL146751A0 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias
RU99123655A (ru) Средство для лечения герпеса
ES1041504Y (es) Colchon perfeccionado enrollado al vacio.
ITRM990341A0 (it) Dispositivo per il trattamento per via magnetica di acque da depurare.
RU98112366A (ru) Препарат для лечения зудящих заболеваний
HK1051494A (en) Improved treatment for acute physical insult to the central nervous system
SI1192154T1 (en) Bispidine compounds useful in the treatment of cardiac arrhythmias
ZA200002170B (en) Treatment of acarids.
GB9928852D0 (en) Compound for use in water treatment
GB9928845D0 (en) Compound for use in water treatment